✦ LIBER ✦

Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a hellenic co-operative oncology group study

✍ Scribed by D.V. Skarlos; G. Aravantinos; P. Kosmidis; N. Pavlidis; K. Gennatas; M. Beer; N. Mylonakis; P. Makrantonakis; G. Klouvas; S. Karpathios; H. Linardou; C. Konstantaras; G. Fountzilas

Book ID: 116166613
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 951 KB
Volume: 32
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)00537-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Co-expression of angiogenic markers and

Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: A Gynecologic Oncology Group study

✍ Angeles Alvarez Secord; Kathleen M. Darcy; Alan Hutson; Paula S. Lee; Laura J. H 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 603 KB

Combination chemotherapy with cisplatin,

Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group

✍ Pectasides, D.; Samantas, E.; Fountzilas, G.; Briasoulis, E.; Kosmidis, P.; Skar 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Phase I feasibility trial of carboplatin

Phase I feasibility trial of carboplatin, paclitaxel, and gemcitabine in patients with previously untreated epithelial ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study

✍ Katherine Y Look; Michael A Bookman; Jessie Schol; Thomas J Herzog; Thomas Rocer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Gemcitabine and carboplatin combination

Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group

✍ Helena Linardou; Gerassimos Aravantinos; Eleni Efstathiou; Charalambos Kalofonos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Paclitaxel and carboplatin as first-line

Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group

✍ George Fountzilas; Dimitrios Pectasides; Anna Kalogera-Fountzila; Dimosthenis Sk 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

A phase I trial of dose-dense (biweekly)

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study

✍ Amy D. Tiersten; Michael W. Sill; Danielle Knight; Franco Muggia; Agustin A. Gar 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 226 KB